Working with a proactive medical team is your
strongest weapon in the fight against mesothelioma.
Additionally, patient education and awareness is
extremely important. We have provided the following
mesothelioma help resources to help patients and families stay
up-to-date.
CLINICAL
TRIALS |
MESOTHELIOMA NEWS
|
EMAIL
ALERTS

Results from recent studies confirm that Alimta®, Eli Lilly's FDA-approved drug for
mesothelioma,
has
clinical efficacy for the treatment of
malignant pleural mesothelioma.
Approved in 2004, Alimta Therapy is considered the chemotherapy standard of care for treatment of mesothelioma.
CONTINUE READING

CD200
is a protein that shows promise as a biomarker for many types of cancer.
Researchers from France have recently completed a study that looked at CD200 expression in
malignant mesothelioma and
in
lung cancer and have concluded that it does hold
promise as a diagnostic factor for these diseases.
CONTINUE READING